Position in MRK
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$3,591,832
+$2,326,863 QoQ
Shares Held
27,952
+165.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#1,230
of 3,778 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SNS Financial Group, LLC holds $152,677,395 across 10 Drug Manufacturers - General names. MRK ranks #6 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
46,863 | $56,208,892 | |
| 2 | JNJ |
Johnson & Johnson
|
172,754 | $43,874,333 | |
| 3 | NVO |
Novo Nordisk A S
|
669,858 | $32,112,992 | |
| 4 | ABBV |
AbbVie Inc.
|
32,457 | $8,167,479 | |
| 5 | PFE |
Pfizer Inc
|
167,096 | $4,023,671 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
27,952 | $3,591,832 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
36,127 | $2,081,637 | |
| 8 | AMGN |
Amgen Inc
|
2,842 | $1,029,145 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,591,832 | 27,952 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,264,969 | 10,516 | Shares | Defined | 2026-04-14 | |
| 2025-12-31 | $1,006,916 | 9,566 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $768,714 | 9,159 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $731,279 | 9,238 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $845,448 | 9,419 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $950,331 | 9,553 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $1,080,523 | 9,515 | Shares | Defined | 2024-11-01 | |
| 2024-06-30 | $1,224,505 | 9,891 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $1,343,250 | 10,180 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $1,136,969 | 10,429 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $1,541,366 | 14,972 | Shares | Defined | 2023-10-19 | |
| 2023-06-30 | $2,842,632 | 24,635 | Shares | Defined | 2023-07-17 | |
| 2023-03-31 | $3,210,850 | 30,180 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $4,107,701 | 37,023 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $3,201,682 | 37,177 | Shares | Defined | 2022-10-12 | |
| 2022-06-30 | $3,402,828 | 37,324 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $3,064,321 | 37,347 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,857,215 | 37,281 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,721,085 | 36,228 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,727,782 | 35,075 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $2,577,120 | 33,430 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,711,995 | 33,154 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $592,760 | 7,146 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $553,064 | 7,152 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $549,889 | 7,147 | Shares | Defined | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||